Urinary bladder cancer is the fourth most common malignancy in the Western world. Transitional cell carcinoma (TCC) is the most common subtype, accounting for about 90% of all bladder cancers. The TP53 gene plays an essential role in the regulation of the cell cycle and apoptosis and therefore contributes to cellular transformation and malignancy; however, little is known about the differential gene expression patterns in human tumors that present with the wild-type or mutated TP53 gene. Therefore, because gene profiling can provide new insights into the molecular biology of bladder cancer, the present study aimed to compare the molecular profiles of bladder cancer cell lines with different TP53 alleles, including the wild type (RT4) and tw...
The choice of treatment for bladder tumors is based on pathological criteria, i.e. staging and gradi...
p53 mutation is commonly associated with high-grade, high-stage human urothelial carcinomas. Recent ...
The p53 gene status (mutation) and protein alterations (nuclear accumulation detectable by immunohis...
Urinary bladder cancer is the fourth most common malignancy in the Western world. Transitional cell ...
Urinary bladder cancer is the fourth most common malignancy in the Western world. Transitional cell ...
Urinary bladder cancer is the fourth most common malignancy in the Western world. Transitional cell ...
Urinary bladder neoplasm is the ninth most common cancer in Europe and the United States. The incide...
<p>Molecular and kinetic analyses have contributed to our understanding of the biology of transition...
p53 pathway is important in tumorigenesis. However, no study has been performed to specifically inve...
Problem Statement: Transitional Cell Carcinoma (TCC) of the bladder is a significant health problem ...
Non-muscle invasive bladder cancer (NMIBC) represents a crucial problem for the national health care...
The choice of treatment for bladder tumors is based on pathological criteria, i.e. staging and gradi...
Background: The tumor suppressor gene TP53 is frequently mutated or inactivated in bladder cancer (B...
The choice of treatment for bladder tumors is based on pathological criteria, i.e. staging and gradi...
The choice of treatment for bladder tumors is based on pathological criteria, i.e. staging and gradi...
The choice of treatment for bladder tumors is based on pathological criteria, i.e. staging and gradi...
p53 mutation is commonly associated with high-grade, high-stage human urothelial carcinomas. Recent ...
The p53 gene status (mutation) and protein alterations (nuclear accumulation detectable by immunohis...
Urinary bladder cancer is the fourth most common malignancy in the Western world. Transitional cell ...
Urinary bladder cancer is the fourth most common malignancy in the Western world. Transitional cell ...
Urinary bladder cancer is the fourth most common malignancy in the Western world. Transitional cell ...
Urinary bladder neoplasm is the ninth most common cancer in Europe and the United States. The incide...
<p>Molecular and kinetic analyses have contributed to our understanding of the biology of transition...
p53 pathway is important in tumorigenesis. However, no study has been performed to specifically inve...
Problem Statement: Transitional Cell Carcinoma (TCC) of the bladder is a significant health problem ...
Non-muscle invasive bladder cancer (NMIBC) represents a crucial problem for the national health care...
The choice of treatment for bladder tumors is based on pathological criteria, i.e. staging and gradi...
Background: The tumor suppressor gene TP53 is frequently mutated or inactivated in bladder cancer (B...
The choice of treatment for bladder tumors is based on pathological criteria, i.e. staging and gradi...
The choice of treatment for bladder tumors is based on pathological criteria, i.e. staging and gradi...
The choice of treatment for bladder tumors is based on pathological criteria, i.e. staging and gradi...
p53 mutation is commonly associated with high-grade, high-stage human urothelial carcinomas. Recent ...
The p53 gene status (mutation) and protein alterations (nuclear accumulation detectable by immunohis...